Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex & ORCID
How has Kim M. Hirshfield's publication output changed over time?
ScholarIQpublication output · 2006–2024
Output grew0% over the shown period — from 1 works in 2006 to 1 in 2024.
1
2
1
2
2
2
1
2006201320142016201720182024
What are the most-cited papers on Kim M. Hirshfield?
ScholarIQmost cited works
Immune activation and response to pembrolizumab in POLE-mutant endometrial cancer
Janice M. Mehnert, Anshuman Panda, Judy Zhong, Kim M. Hirshfield, Sherri Damare, Katherine Lane, Levi Sokol, Mark N. Stein, Lorna Rodriguez-Rodriquez, Howard L. Kaufman, Siraj M. Ali, Jeffrey S. Ross, Dean C. Pavlick, Gyan Bhanot, Eileen White, Robert S. DiPaola, Ann Lovell, Jonathan D. Cheng, Shridar Ganesan
S114430552. 2016392 CitationsOPEN ACCESS
MDM2 SNP309 Accelerates Tumor Formation in a Gender-Specific and Hormone-Dependent Manner
Gareth L. Bond, Kim M. Hirshfield, Tomas Kirchhoff, Gabriella Alexe, Elisabeth E. Bond, Harlan Robins, Frank Bartel, Helge Täubert, Peter Wuerl, William N. Hait, Deborah Toppmeyer, Kenneth Offit, Arnold J. Levine
Cancer Research. 2006287 Citations
Contribution of serine, folate and glycine metabolism to the ATP, NADPH and purine requirements of cancer cells
Philip M. Tedeschi, Elke Markert, Murugesan Gounder, Huan Lin, Dmitri Dvorzhinski, Sonia Dolfi, L L-Y Chan, J. Qiu, Robert S. DiPaola, Kim M. Hirshfield, László G. Boros, Joseph R. Bertino, Zoltán N. Oltvai, Alexei Vázquez
Cell Death and Disease. 2013268 CitationsOPEN ACCESS
Molecular Characterization of Epithelial Ovarian Cancer: Implications for Diagnosis and Treatment
Verónica Rojas, Kim M. Hirshfield, Shridar Ganesan, Lorna Rodríguez-Rodríguez
International Journal of Molecular Sciences. 2016263 CitationsOPEN ACCESS
Immune Activation and Benefit From Avelumab in EBV-Positive Gastric Cancer
Anshuman Panda, Janice M. Mehnert, Kim M. Hirshfield, Gregory Riedlinger, Sherri Damare, Tracie Saunders, Michael P. Kane, Levi Sokol, Mark N. Stein, Elizabeth Poplin, Lorna Rodríguez-Rodríguez, Ann W. Silk, Joseph Aisner, Nancy Chan, Jyoti Malhotra, Melissa Frankel, Howard L. Kaufman, Siraj M. Ali, Jeffrey S. Ross, Eileen White, Gyan Bhanot, Shridar Ganesan
JNCI Journal of the National Cancer Institute. 2017216 CitationsOPEN ACCESS
Related on ScholarIQ
Merck & Co., Inc., Rahway, NJ, USA (United States)
Institution
Immune activation and response to pembrolizumab in POLE-mutant endometrial cancer
Paper
MDM2 SNP309 Accelerates Tumor Formation in a Gender-Specific and Hormone-Dependent Manner
Paper
Contribution of serine, folate and glycine metabolism to the ATP, NADPH and purine requirements of cancer cells
Paper
Molecular Characterization of Epithelial Ovarian Cancer: Implications for Diagnosis and Treatment
Paper
Immune Activation and Benefit From Avelumab in EBV-Positive Gastric Cancer
Paper